Sign inJoin waitlistJoin the waitlist

YS

Yazeed Y Sawalha

Physician · Ohio State University College of Medicine

Credentials: · · · · ·

History

Ohio State University College of Medicine
2019–Present

Hematology and Medical Oncology
Cleveland Clinic Foundation
2014–2017
Internal Medicine
2011–2014
Doctor of Medicine
2007–2011

Research

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era
Journal of Clinical Oncology · 2019 · 79 citations
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
Blood Advances · 2021 · 39 citations
Management of older adults with acute lymphoblastic leukemia: challenges & current approaches
Review · International Journal of Hematologic Oncology · 2018 · First of 2 authors · Corresponding · 32 citations

Kami Maddocks
28 papers
David Bond
26 papers · 1 as a fellow
Narendranath Epperla
26 papers
Beth Christian
22 papers
Robert Baiocchi
19 papers
Lapo Alinari
18 papers
TV
Timothy Voorhees
18 papers · 4 as a fellow
Brian Hill
12 papers
Reem Karmali
12 papers
Audrey Sigmund
11 papers
JR
John Reneau
11 papers
Jonathan Brammer
11 papers

Clinical trials

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Principal investigator · Recruiting · Phase 1, Phase 2
Yazeed Sawalha
2025–2027
Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Principal investigator · Withdrawn · Phase 1
Yazeed Sawalha
2022–2024
Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
Principal investigator · Active not recruiting · Phase 1
Yazeed Sawalha
2021–2026
Epco, Zanu, Ritux for R/R FL or MZL
Site PI · Recruiting · Phase 2
Reid Merryman, MD
2025–2030